投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量20.63% (2022年為21.21%)
自引率
3.3 %
年文章數(shù)
3635
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):17165)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):5101次)
作者需知
點(diǎn)擊查看
(點(diǎn)擊次數(shù):1301次)
NCBI查詢
偏重的研究方向
期刊簡(jiǎn)介
稿件收錄要求
稿件收錄要求
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.
The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.
The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.
常用鏈接
期刊論壇
|
中國(guó)SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
